|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/00 | |
| A61K 45/06 | |||
| A61K 31/155 | |||
| C07D 223/16 | |||
| A23P 20/12 | |||
| A61K 31/55 | |||
| A61K 9/20 | |||
| A61K 9/28 | |||
| A61K 31/135 |
| (11) | Patento numeris | 2611427 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11755504.5 |
| Europos patento paraiškos padavimo data | 2011-08-31 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-07-10 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-10-17 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2011/049914 |
| Data | 2011-08-31 |
| (87) | Numeris | WO 2012/030927 |
| Data | 2012-03-08 |
| (30) | Numeris | Data | Šalis |
| 403143 P | 2010-09-10 | US | |
| 402578 P | 2010-09-01 | US |
| (72) |
SHAO, Zezhi Jesse, US
BLACKBURN, Anthony C., US
GROTTICK, Andrew J., US
MORGAN, Michael, US
RUETER, Jaimie Karyn, US
SHIFRINA, Anna, US
STIRN, Scott, US
YANG, Libo, US
YOON, Woo Hyun, US
|
| (73) |
Arena Pharmaceuticals, Inc.,
6154 Nancy Ridge Drive, San Diego, CA 92121,
US
|
| (54) | MODIFIED-RELEASE DOSAGE FORMS OF 5-HT2C AGONISTS USEFUL FOR WEIGHT MANAGEMENT |
| MODIFIED-RELEASE DOSAGE FORMS OF 5-HT2C AGONISTS USEFUL FOR WEIGHT MANAGEMENT |